Alpha Tau Medical
DRTS
26 hedge funds and large institutions have $5.51M invested in Alpha Tau Medical in 2023 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 5 closing their positions.
300% more repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 1
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
51% more capital invested
Capital invested by funds: $3.65M → $5.51M (+$1.85M)
13% more funds holding
Funds holding: 23 → 26 (+3)
1.25% more ownership
Funds ownership: 1.4% → 2.65% (+1.2%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$853K |
| 2 |
LCS
Levin Capital Strategies
New York
|
+$789K |
| 3 |
HighTower Advisors
Chicago,
Illinois
|
+$684K |
| 4 |
PAG
Private Advisor Group
Morristown,
New Jersey
|
+$188K |
| 5 |
SAM
Satovsky Asset Management
New York
|
+$188K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
-$150K |
| 2 |
PMG
ProVise Management Group
Clearwater,
Florida
|
-$133K |
| 3 |
Citigroup
New York
|
-$56.7K |
| 4 |
CWM
Circle Wealth Management
Summit,
New Jersey
|
-$55K |
| 5 |
AWM
Activest Wealth Management
Aventure,
Florida
|
-$13.1K |
DRTS Hedge Fund Activity: Q4 2023 in Review
26 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Alpha Tau Medical (DRTS) for Q4 2023, worth a combined $5.51M — up 51% from $3.65M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new DRTS positions and 5 closed out — a net gain of 3 holders — while 4 added to existing stakes and 1 trimmed.
The largest buyer was Morgan Stanley, adding an estimated $853K. The largest seller was JP Morgan Chase, exiting entirely with an estimated $150K sold.
- 26 institutional investors held Alpha Tau Medical (DRTS) as of Q4 2023, up from 23 in Q3 2023.
- Funds reported $5.51M of Alpha Tau Medical stock for Q4 2023, up 51% quarter-over-quarter.
- 8 funds opened new Alpha Tau Medical positions in Q4 2023 and 5 closed out, a net change of +3 holders.
- The largest Alpha Tau Medical buyer in Q4 2023 was Morgan Stanley, an estimated $853K added.
- The largest Alpha Tau Medical seller in Q4 2023 was JP Morgan Chase, an estimated $150K sold.
Based on aggregated 13F filings for Q4 2023.